Brief summaries of recent advances in device research and clinical trials, including a new study sugesting that treating post-PCI patients with vascular closure devices in combination with bivalirudin have substantially reduced bleeding rates, and a large study of postmeenopausal women indicated that tracking CA-125 may be an effective way to detect early-stage ovarian cancer.
by Cheri Thompson
A large study suggests patients who undergo percutaneous coronary intervention (PCI) procedures have substantially reduced bleeding rates when treated with vascular closure devices in combination with bivalirudin, a reversible direct...